

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of B cell apoptotic process (GO:0002902) | 9.71876630 |
| 2 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 8.95444243 |
| 3 | immunoglobulin mediated immune response (GO:0016064) | 8.79015324 |
| 4 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 8.70260137 |
| 5 | positive regulation of lipoprotein lipase activity (GO:0051006) | 8.56023947 |
| 6 | positive regulation of triglyceride lipase activity (GO:0061365) | 8.56023947 |
| 7 | regulation of memory T cell differentiation (GO:0043380) | 8.55617543 |
| 8 | negative regulation of digestive system process (GO:0060457) | 8.55495622 |
| 9 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 8.48789604 |
| 10 | regulation of T-helper 2 cell differentiation (GO:0045628) | 8.34620595 |
| 11 | regulation of cholesterol homeostasis (GO:2000188) | 8.06962745 |
| 12 | negative regulation of type 2 immune response (GO:0002829) | 7.85531799 |
| 13 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 7.72273888 |
| 14 | germinal center formation (GO:0002467) | 7.48437895 |
| 15 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 7.45982510 |
| 16 | T cell apoptotic process (GO:0070231) | 7.11158577 |
| 17 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 7.02774853 |
| 18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.98234177 |
| 19 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.95294754 |
| 20 | negative regulation of cell killing (GO:0031342) | 6.95294754 |
| 21 | regulation of mitotic spindle organization (GO:0060236) | 6.81530426 |
| 22 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 6.71075358 |
| 23 | regulation of cholesterol storage (GO:0010885) | 6.67220154 |
| 24 | B cell mediated immunity (GO:0019724) | 6.50673741 |
| 25 | positive regulation of receptor biosynthetic process (GO:0010870) | 6.40736057 |
| 26 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.37798448 |
| 27 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.37798448 |
| 28 | modulation by symbiont of host immune response (GO:0052553) | 6.37798448 |
| 29 | positive regulation by symbiont of host defense response (GO:0052509) | 6.37798448 |
| 30 | modulation by symbiont of host defense response (GO:0052031) | 6.37798448 |
| 31 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.37798448 |
| 32 | response to food (GO:0032094) | 6.33348449 |
| 33 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 6.31808676 |
| 34 | regulation of germinal center formation (GO:0002634) | 6.21065075 |
| 35 | lymphocyte apoptotic process (GO:0070227) | 6.19083405 |
| 36 | positive regulation of cholesterol efflux (GO:0010875) | 6.00425228 |
| 37 | apoptotic cell clearance (GO:0043277) | 6.00406930 |
| 38 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.88220539 |
| 39 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 5.86867544 |
| 40 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.85593693 |
| 41 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 5.84162592 |
| 42 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 5.80383725 |
| 43 | NLS-bearing protein import into nucleus (GO:0006607) | 5.77008813 |
| 44 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.61999506 |
| 45 | negative regulation of Rho protein signal transduction (GO:0035024) | 5.49821827 |
| 46 | neutrophil activation involved in immune response (GO:0002283) | 5.37686812 |
| 47 | positive regulation of sterol transport (GO:0032373) | 5.34211969 |
| 48 | positive regulation of cholesterol transport (GO:0032376) | 5.34211969 |
| 49 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.30795464 |
| 50 | negative regulation of cytokine production involved in immune response (GO:0002719) | 5.28124723 |
| 51 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.23127461 |
| 52 | detection of other organism (GO:0098543) | 5.22957200 |
| 53 | regulation of triglyceride biosynthetic process (GO:0010866) | 5.22035048 |
| 54 | macrophage activation involved in immune response (GO:0002281) | 5.20780051 |
| 55 | negative regulation of lipid storage (GO:0010888) | 5.19839748 |
| 56 | detection of molecule of bacterial origin (GO:0032490) | 5.16195070 |
| 57 | cytokine biosynthetic process (GO:0042089) | 4.98212314 |
| 58 | positive regulation of triglyceride metabolic process (GO:0090208) | 4.97784087 |
| 59 | detection of bacterium (GO:0016045) | 4.84957585 |
| 60 | detection of external biotic stimulus (GO:0098581) | 4.78813871 |
| 61 | response to interleukin-15 (GO:0070672) | 4.74166587 |
| 62 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.71355608 |
| 63 | cellular extravasation (GO:0045123) | 4.71306225 |
| 64 | negative regulation of alpha-beta T cell activation (GO:0046636) | 4.66116345 |
| 65 | leukocyte apoptotic process (GO:0071887) | 4.60081048 |
| 66 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.58314202 |
| 67 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.57737853 |
| 68 | neutrophil activation (GO:0042119) | 4.57203725 |
| 69 | auditory behavior (GO:0031223) | 4.55724736 |
| 70 | C4-dicarboxylate transport (GO:0015740) | 4.55621693 |
| 71 | response to peptidoglycan (GO:0032494) | 4.55144890 |
| 72 | cellular response to interleukin-15 (GO:0071350) | 4.49502673 |
| 73 | regulation of spindle organization (GO:0090224) | 4.42796134 |
| 74 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.40185457 |
| 75 | L-amino acid import (GO:0043092) | 4.38697901 |
| 76 | respiratory burst (GO:0045730) | 4.36883564 |
| 77 | apoptotic DNA fragmentation (GO:0006309) | 4.34594775 |
| 78 | negative regulation of leukocyte apoptotic process (GO:2000107) | 4.34502990 |
| 79 | leukocyte aggregation (GO:0070486) | 4.31851069 |
| 80 | negative regulation of interleukin-12 production (GO:0032695) | 4.29951559 |
| 81 | microglial cell activation (GO:0001774) | 4.29921043 |
| 82 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 4.28969003 |
| 83 | response to host immune response (GO:0052572) | 4.28567025 |
| 84 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.28567025 |
| 85 | neutrophil mediated immunity (GO:0002446) | 4.26301474 |
| 86 | regulation of gamma-delta T cell activation (GO:0046643) | 4.26233105 |
| 87 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.21102144 |
| 88 | negative regulation of innate immune response (GO:0045824) | 4.20571148 |
| 89 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.18026642 |
| 90 | regulation of cholesterol efflux (GO:0010874) | 4.17698422 |
| 91 | response to fungus (GO:0009620) | 4.16262648 |
| 92 | detection of biotic stimulus (GO:0009595) | 4.12799303 |
| 93 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.11002794 |
| 94 | proteasome assembly (GO:0043248) | 4.10140678 |
| 95 | granulocyte activation (GO:0036230) | 4.06035984 |
| 96 | cytokine metabolic process (GO:0042107) | 4.02229416 |
| 97 | macrophage activation (GO:0042116) | 3.96875259 |
| 98 | response to host (GO:0075136) | 3.95102833 |
| 99 | response to host defenses (GO:0052200) | 3.95102833 |
| 100 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.95102833 |
| 101 | regulation of cytokine production involved in immune response (GO:0002718) | 3.92661830 |
| 102 | erythrocyte development (GO:0048821) | 3.90855745 |
| 103 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.88465482 |
| 104 | negative regulation of T cell mediated immunity (GO:0002710) | 3.83953789 |
| 105 | ADP metabolic process (GO:0046031) | 3.83122779 |
| 106 | negative regulation of DNA recombination (GO:0045910) | 3.78119638 |
| 107 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.78038342 |
| 108 | myeloid cell activation involved in immune response (GO:0002275) | 3.77294685 |
| 109 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.76991587 |
| 110 | regulation of mast cell degranulation (GO:0043304) | 3.67044283 |
| 111 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.64978570 |
| 112 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.63032456 |
| 113 | positive regulation of interleukin-8 production (GO:0032757) | 3.62493005 |
| 114 | positive regulation of cytokine production involved in immune response (GO:0002720) | 3.60095038 |
| 115 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.57700555 |
| 116 | myeloid leukocyte mediated immunity (GO:0002444) | 3.56463462 |
| 117 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.55285168 |
| 118 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.52531618 |
| 119 | B cell receptor signaling pathway (GO:0050853) | 3.51698208 |
| 120 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.51504176 |
| 121 | regulation of lymphocyte apoptotic process (GO:0070228) | 3.51340511 |
| 122 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 3.49317631 |
| 123 | positive regulation of mast cell activation (GO:0033005) | 3.47872807 |
| 124 | regulation of triglyceride metabolic process (GO:0090207) | 3.47361588 |
| 125 | triglyceride homeostasis (GO:0070328) | 3.47216734 |
| 126 | acylglycerol homeostasis (GO:0055090) | 3.47216734 |
| 127 | regulation of response to interferon-gamma (GO:0060330) | 3.46903873 |
| 128 | regulation of receptor biosynthetic process (GO:0010869) | 3.46882936 |
| 129 | protein import into nucleus, translocation (GO:0000060) | 3.46731806 |
| 130 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.45246660 |
| 131 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.44127536 |
| 132 | regulation of T-helper cell differentiation (GO:0045622) | 3.40121556 |
| 133 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.39949238 |
| 134 | regulation of T cell tolerance induction (GO:0002664) | 3.38158357 |
| 135 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.35976234 |
| 136 | dendritic cell migration (GO:0036336) | 3.35867012 |
| 137 | negative regulation of phagocytosis (GO:0050765) | 3.33392822 |
| 138 | negative regulation of lipid transport (GO:0032369) | 3.32984797 |
| 139 | leukocyte degranulation (GO:0043299) | 3.32320761 |
| 140 | cellular response to type I interferon (GO:0071357) | 3.29011617 |
| 141 | type I interferon signaling pathway (GO:0060337) | 3.29011617 |
| 142 | regulation of tolerance induction (GO:0002643) | 3.28463974 |
| 143 | regulation of B cell differentiation (GO:0045577) | 3.27060878 |
| 144 | response to type I interferon (GO:0034340) | 3.26443905 |
| 145 | dendritic cell chemotaxis (GO:0002407) | 3.25372750 |
| 146 | endothelium development (GO:0003158) | 3.24020359 |
| 147 | regulation of type 2 immune response (GO:0002828) | 3.23733557 |
| 148 | regulation of leukocyte degranulation (GO:0043300) | 3.21832182 |
| 149 | regulation of mast cell activation (GO:0033003) | 3.21623078 |
| 150 | negative thymic T cell selection (GO:0045060) | 3.21229584 |
| 151 | amino acid import (GO:0043090) | 3.19849665 |
| 152 | response to thyroid hormone (GO:0097066) | 3.19478229 |
| 153 | negative T cell selection (GO:0043383) | 3.18116539 |
| 154 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.16659232 |
| 155 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.16461922 |
| 156 | regulation of macrophage activation (GO:0043030) | 3.15357510 |
| 157 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.15119380 |
| 158 | mechanosensory behavior (GO:0007638) | 3.14851257 |
| 159 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.13974657 |
| 160 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.12645018 |
| 161 | defense response to protozoan (GO:0042832) | 3.09637513 |
| 162 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 3.08953864 |
| 163 | AMP metabolic process (GO:0046033) | 3.07082613 |
| 164 | response to muramyl dipeptide (GO:0032495) | 3.02035627 |
| 165 | neurotransmitter uptake (GO:0001504) | 3.01246341 |
| 166 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.00519048 |
| 167 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.00209825 |
| 168 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.00209825 |
| 169 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.99454440 |
| 170 | tolerance induction (GO:0002507) | 2.99362470 |
| 171 | regulation of regulatory T cell differentiation (GO:0045589) | 2.99296960 |
| 172 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.98131314 |
| 173 | negative regulation of interleukin-6 production (GO:0032715) | 2.96446336 |
| 174 | positive regulation of B cell differentiation (GO:0045579) | 2.95321041 |
| 175 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.92944506 |
| 176 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.92906357 |
| 177 | activated T cell proliferation (GO:0050798) | 2.92634063 |
| 178 | regulation of regulated secretory pathway (GO:1903305) | 2.90915878 |
| 179 | myeloid leukocyte activation (GO:0002274) | 2.90540675 |
| 180 | positive thymic T cell selection (GO:0045059) | 2.90135462 |
| 181 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.89872598 |
| 182 | regulation of isotype switching (GO:0045191) | 2.88582458 |
| 183 | regulation of digestive system process (GO:0044058) | 2.79641151 |
| 184 | negative regulation of B cell apoptotic process (GO:0002903) | 15.0922802 |
| 185 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 12.7272106 |
| 186 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 10.3805068 |
| 187 | negative regulation of B cell mediated immunity (GO:0002713) | 10.3805068 |
| 188 | negative regulation of T-helper cell differentiation (GO:0045623) | 10.3538816 |
| 189 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 10.3538816 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.32090659 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 6.18112578 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.49401298 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.18410027 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.14139908 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.38394606 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.76829427 |
| 8 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.76661775 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.72067605 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.69042212 |
| 11 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.57882152 |
| 12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.57555243 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.55534078 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.52402557 |
| 15 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 2.51416155 |
| 16 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.43905668 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.35890952 |
| 18 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.29634306 |
| 19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.28121774 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.28012371 |
| 21 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.26665993 |
| 22 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.15912722 |
| 23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.14373379 |
| 24 | GATA1_22025678_ChIP-Seq_K562_Human | 2.13490774 |
| 25 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.12031766 |
| 26 | MAF_26560356_Chip-Seq_TH1_Human | 2.08159029 |
| 27 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.07795852 |
| 28 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.06255206 |
| 29 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.04897090 |
| 30 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.04803760 |
| 31 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.01914444 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.00042935 |
| 33 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.96371928 |
| 34 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.96067985 |
| 35 | MYB_26560356_Chip-Seq_TH2_Human | 1.92153851 |
| 36 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.91356946 |
| 37 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88438914 |
| 38 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.86516363 |
| 39 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.74780994 |
| 40 | TP53_16413492_ChIP-PET_HCT116_Human | 1.68499518 |
| 41 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.68084548 |
| 42 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.65063158 |
| 43 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.63868842 |
| 44 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.61254795 |
| 45 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61141976 |
| 46 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.59580246 |
| 47 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.58444826 |
| 48 | MYC_22102868_ChIP-Seq_BL_Human | 1.56719190 |
| 49 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.56639514 |
| 50 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.54609761 |
| 51 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.54387542 |
| 52 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.53956407 |
| 53 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.53290598 |
| 54 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.52532793 |
| 55 | SPI1_23127762_ChIP-Seq_K562_Human | 1.51041812 |
| 56 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.44974588 |
| 57 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.43221641 |
| 58 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.42918197 |
| 59 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.41914971 |
| 60 | MYB_26560356_Chip-Seq_TH1_Human | 1.41082801 |
| 61 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.36019541 |
| 62 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.35488905 |
| 63 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35445376 |
| 64 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.35092308 |
| 65 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.34573532 |
| 66 | GATA2_19941826_ChIP-Seq_K562_Human | 1.34200668 |
| 67 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.32589650 |
| 68 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.30637435 |
| 69 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.29093083 |
| 70 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28507064 |
| 71 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24820326 |
| 72 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23512356 |
| 73 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.22912952 |
| 74 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.22392374 |
| 75 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.21860250 |
| 76 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21349901 |
| 77 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21137172 |
| 78 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20281081 |
| 79 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19810047 |
| 80 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16840086 |
| 81 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.16128663 |
| 82 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15853391 |
| 83 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14854256 |
| 84 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14305069 |
| 85 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.14056818 |
| 86 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13976262 |
| 87 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.12963045 |
| 88 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.12798243 |
| 89 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11372603 |
| 90 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10960798 |
| 91 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.10546717 |
| 92 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.09736050 |
| 93 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09700035 |
| 94 | * EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.09556990 |
| 95 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.08555660 |
| 96 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08496270 |
| 97 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.07736939 |
| 98 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.07434282 |
| 99 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07118599 |
| 100 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.06751143 |
| 101 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.05816912 |
| 102 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.04913974 |
| 103 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.03422689 |
| 104 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.01460591 |
| 105 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00540132 |
| 106 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99165491 |
| 107 | CJUN_26792858_Chip-Seq_BT549_Human | 0.96787642 |
| 108 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.96140042 |
| 109 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.95789972 |
| 110 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.95166836 |
| 111 | UTX_26944678_Chip-Seq_JUKART_Human | 0.94609646 |
| 112 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.94529292 |
| 113 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.94347004 |
| 114 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.94347004 |
| 115 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.93293781 |
| 116 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93104193 |
| 117 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.93099727 |
| 118 | MAF_26560356_Chip-Seq_TH2_Human | 0.90767305 |
| 119 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.90607677 |
| 120 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88920610 |
| 121 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.88606864 |
| 122 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.88010080 |
| 123 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.86897860 |
| 124 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.86199635 |
| 125 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.85749910 |
| 126 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.84125961 |
| 127 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.84125961 |
| 128 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.83119880 |
| 129 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81740763 |
| 130 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.80631847 |
| 131 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80617535 |
| 132 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.79493775 |
| 133 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79159727 |
| 134 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.78921470 |
| 135 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.77519080 |
| 136 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.76510190 |
| 137 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75366904 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003191_abnormal_cellular_cholesterol | 8.76079427 |
| 2 | MP0003329_amyloid_beta_deposits | 4.99404627 |
| 3 | MP0005365_abnormal_bile_salt | 4.26447115 |
| 4 | MP0000604_amyloidosis | 3.69584732 |
| 5 | MP0001853_heart_inflammation | 3.36081859 |
| 6 | MP0000685_abnormal_immune_system | 2.78498727 |
| 7 | MP0002132_abnormal_respiratory_system | 2.31201068 |
| 8 | MP0004145_abnormal_muscle_electrophysio | 2.13085730 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 13.5815862 |
| 10 | MP0005647_abnormal_sex_gland | 1.99931338 |
| 11 | MP0003183_abnormal_peptide_metabolism | 1.97863251 |
| 12 | MP0004381_abnormal_hair_follicle | 1.97740541 |
| 13 | MP0002277_abnormal_respiratory_mucosa | 1.94063201 |
| 14 | MP0003828_pulmonary_edema | 1.87033480 |
| 15 | MP0003303_peritoneal_inflammation | 1.79784176 |
| 16 | MP0003806_abnormal_nucleotide_metabolis | 1.76731533 |
| 17 | MP0005451_abnormal_body_composition | 1.71048838 |
| 18 | MP0004270_analgesia | 1.59555142 |
| 19 | MP0004883_abnormal_blood_vessel | 1.57985230 |
| 20 | MP0010329_abnormal_lipoprotein_level | 1.52955999 |
| 21 | MP0001790_abnormal_immune_system | 1.50438556 |
| 22 | MP0005387_immune_system_phenotype | 1.50438556 |
| 23 | MP0001800_abnormal_humoral_immune | 1.41310803 |
| 24 | MP0003632_abnormal_nervous_system | 1.36097910 |
| 25 | MP0005025_abnormal_response_to | 1.32874126 |
| 26 | MP0005310_abnormal_salivary_gland | 1.32670006 |
| 27 | MP0000858_altered_metastatic_potential | 1.29339261 |
| 28 | MP0005164_abnormal_response_to | 1.24691014 |
| 29 | MP0000465_gastrointestinal_hemorrhage | 1.22249581 |
| 30 | MP0005360_urolithiasis | 1.21930244 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 1.19238881 |
| 32 | MP0005319_abnormal_enzyme/_coenzyme | 1.18676494 |
| 33 | MP0002452_abnormal_antigen_presenting | 1.11342893 |
| 34 | MP0003436_decreased_susceptibility_to | 1.10732203 |
| 35 | MP0002998_abnormal_bone_remodeling | 1.07630261 |
| 36 | MP0000609_abnormal_liver_physiology | 1.07574135 |
| 37 | MP0005075_abnormal_melanosome_morpholog | 1.05246277 |
| 38 | MP0001835_abnormal_antigen_presentation | 1.05241833 |
| 39 | MP0005058_abnormal_lysosome_morphology | 1.03989543 |
| 40 | * MP0008469_abnormal_protein_level | 1.02974128 |
| 41 | MP0002419_abnormal_innate_immunity | 0.99175896 |
| 42 | MP0004510_myositis | 0.98759401 |
| 43 | MP0002405_respiratory_system_inflammati | 0.98502502 |
| 44 | MP0003880_abnormal_central_pattern | 0.95231579 |
| 45 | MP0003724_increased_susceptibility_to | 0.95189517 |
| 46 | MP0009379_abnormal_foot_pigmentation | 0.94399713 |
| 47 | MP0001845_abnormal_inflammatory_respons | 0.93261871 |
| 48 | MP0002166_altered_tumor_susceptibility | 0.93130180 |
| 49 | MP0008004_abnormal_stomach_pH | 0.92540128 |
| 50 | MP0005671_abnormal_response_to | 0.92456540 |
| 51 | MP0003631_nervous_system_phenotype | 0.92019631 |
| 52 | MP0009785_altered_susceptibility_to | 0.91347648 |
| 53 | MP0000689_abnormal_spleen_morphology | 0.91307688 |
| 54 | MP0005000_abnormal_immune_tolerance | 0.91201638 |
| 55 | * MP0002723_abnormal_immune_serum | 0.91137418 |
| 56 | MP0009840_abnormal_foam_cell | 0.89307466 |
| 57 | MP0003656_abnormal_erythrocyte_physiolo | 0.88972132 |
| 58 | MP0005464_abnormal_platelet_physiology | 0.86723632 |
| 59 | * MP0002420_abnormal_adaptive_immunity | 0.85386674 |
| 60 | MP0004130_abnormal_muscle_cell | 0.84799767 |
| 61 | MP0003045_fibrosis | 0.84723332 |
| 62 | * MP0001819_abnormal_immune_cell | 0.84522894 |
| 63 | MP0005390_skeleton_phenotype | 0.84155756 |
| 64 | MP0003448_altered_tumor_morphology | 0.82487727 |
| 65 | MP0003221_abnormal_cardiomyocyte_apopto | 0.80741958 |
| 66 | MP0000569_abnormal_digit_pigmentation | 0.80695610 |
| 67 | MP0001986_abnormal_taste_sensitivity | 0.80070928 |
| 68 | MP0001663_abnormal_digestive_system | 0.79726583 |
| 69 | MP0000490_abnormal_crypts_of | 0.79378590 |
| 70 | MP0000747_muscle_weakness | 0.78894454 |
| 71 | MP0008260_abnormal_autophagy | 0.76370320 |
| 72 | MP0005409_darkened_coat_color | 0.74151533 |
| 73 | * MP0002398_abnormal_bone_marrow | 0.72797127 |
| 74 | MP0003300_gastrointestinal_ulcer | 0.72555202 |
| 75 | MP0002332_abnormal_exercise_endurance | 0.69429099 |
| 76 | MP0003075_altered_response_to | 0.68676973 |
| 77 | MP0009763_increased_sensitivity_to | 0.68225314 |
| 78 | MP0002928_abnormal_bile_duct | 0.67687357 |
| 79 | MP0001873_stomach_inflammation | 0.67359351 |
| 80 | MP0008874_decreased_physiological_sensi | 0.67047423 |
| 81 | MP0003633_abnormal_nervous_system | 0.66458826 |
| 82 | MP0000249_abnormal_blood_vessel | 0.66180918 |
| 83 | MP0005377_hearing/vestibular/ear_phenot | 0.65666030 |
| 84 | MP0003878_abnormal_ear_physiology | 0.65666030 |
| 85 | MP0009765_abnormal_xenobiotic_induced | 0.65362200 |
| 86 | MP0003252_abnormal_bile_duct | 0.65274172 |
| 87 | MP0008875_abnormal_xenobiotic_pharmacok | 0.64995396 |
| 88 | MP0002396_abnormal_hematopoietic_system | 0.64410948 |
| 89 | MP0000920_abnormal_myelination | 0.62948887 |
| 90 | MP0002148_abnormal_hypersensitivity_rea | 0.61681879 |
| 91 | MP0005332_abnormal_amino_acid | 0.61133999 |
| 92 | MP0005174_abnormal_tail_pigmentation | 0.60851885 |
| 93 | MP0002138_abnormal_hepatobiliary_system | 0.60098677 |
| 94 | MP0005085_abnormal_gallbladder_physiolo | 0.58685652 |
| 95 | MP0004808_abnormal_hematopoietic_stem | 0.58375809 |
| 96 | MP0000703_abnormal_thymus_morphology | 0.57800442 |
| 97 | MP0003795_abnormal_bone_structure | 0.57442167 |
| 98 | * MP0000716_abnormal_immune_system | 0.55260457 |
| 99 | MP0002006_tumorigenesis | 0.54582636 |
| 100 | MP0004484_altered_response_of | 0.53622986 |
| 101 | MP0004858_abnormal_nervous_system | 0.52810583 |
| 102 | MP0005376_homeostasis/metabolism_phenot | 0.52726359 |
| 103 | MP0005248_abnormal_Harderian_gland | 0.52586479 |
| 104 | MP0003646_muscle_fatigue | 0.52314823 |
| 105 | MP0001533_abnormal_skeleton_physiology | 0.51838698 |
| 106 | MP0002722_abnormal_immune_system | 0.51341726 |
| 107 | MP0002118_abnormal_lipid_homeostasis | 0.50536709 |
| 108 | * MP0002429_abnormal_blood_cell | 0.49589757 |
| 109 | MP0000343_altered_response_to | 0.47351529 |
| 110 | MP0000598_abnormal_liver_morphology | 0.46541287 |
| 111 | MP0005167_abnormal_blood-brain_barrier | 0.46204998 |
| 112 | MP0003186_abnormal_redox_activity | 0.44813809 |
| 113 | MP0005636_abnormal_mineral_homeostasis | 0.41448958 |
| 114 | MP0001851_eye_inflammation | 0.41406932 |
| 115 | MP0010155_abnormal_intestine_physiology | 0.40607196 |
| 116 | MP0008873_increased_physiological_sensi | 0.40470042 |
| 117 | MP0004947_skin_inflammation | 0.39397788 |
| 118 | MP0002876_abnormal_thyroid_physiology | 0.39137065 |
| 119 | MP0006082_CNS_inflammation | 0.37470168 |
| 120 | MP0003763_abnormal_thymus_physiology | 0.36261929 |
| 121 | MP0009764_decreased_sensitivity_to | 0.34462805 |
| 122 | MP0003690_abnormal_glial_cell | 0.33929725 |
| 123 | MP0002933_joint_inflammation | 0.33921114 |
| 124 | * MP0009642_abnormal_blood_homeostasis | 0.33752990 |
| 125 | MP0000015_abnormal_ear_pigmentation | 0.33351177 |
| 126 | MP0010630_abnormal_cardiac_muscle | 0.32844234 |
| 127 | MP0005083_abnormal_biliary_tract | 0.32842320 |
| 128 | MP0003866_abnormal_defecation | 0.30548182 |
| 129 | MP0005397_hematopoietic_system_phenotyp | 0.30499038 |
| 130 | MP0001545_abnormal_hematopoietic_system | 0.30499038 |
| 131 | MP0001915_intracranial_hemorrhage | 0.30125835 |
| 132 | MP0005166_decreased_susceptibility_to | 0.29677761 |
| 133 | MP0010030_abnormal_orbit_morphology | 0.29336965 |
| 134 | MP0006054_spinal_hemorrhage | 0.29306190 |
| 135 | MP0003172_abnormal_lysosome_physiology | 0.27855340 |
| 136 | MP0003635_abnormal_synaptic_transmissio | 0.27644641 |
| 137 | MP0003566_abnormal_cell_adhesion | 0.25753488 |
| 138 | MP0009278_abnormal_bone_marrow | 0.25569806 |
| 139 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.25466827 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Parakeratosis (HP:0001036) | 9.64075040 |
| 2 | Amniotic constriction ring (HP:0009775) | 7.81008061 |
| 3 | Abnormality of placental membranes (HP:0011409) | 7.81008061 |
| 4 | Mediastinal lymphadenopathy (HP:0100721) | 6.87093945 |
| 5 | Abnormality of the peritoneum (HP:0002585) | 6.32986902 |
| 6 | Myositis (HP:0100614) | 6.29099161 |
| 7 | Hemiplegia (HP:0002301) | 6.13744996 |
| 8 | Orchitis (HP:0100796) | 6.05857369 |
| 9 | Optic neuritis (HP:0100653) | 5.65254837 |
| 10 | Retrobulbar optic neuritis (HP:0100654) | 5.65254837 |
| 11 | Nonprogressive disorder (HP:0003680) | 5.37605643 |
| 12 | Severe combined immunodeficiency (HP:0004430) | 5.11556458 |
| 13 | Synostosis involving the elbow (HP:0003938) | 4.95477040 |
| 14 | Humeroradial synostosis (HP:0003041) | 4.95477040 |
| 15 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.92684225 |
| 16 | Type 2 muscle fiber atrophy (HP:0003554) | 4.92231545 |
| 17 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.76250977 |
| 18 | Hypochromic microcytic anemia (HP:0004840) | 4.74040699 |
| 19 | Gastrointestinal infarctions (HP:0005244) | 4.61838679 |
| 20 | Microglossia (HP:0000171) | 4.57840759 |
| 21 | Combined immunodeficiency (HP:0005387) | 4.54643053 |
| 22 | Muscle fiber atrophy (HP:0100295) | 4.45429745 |
| 23 | Hemiparesis (HP:0001269) | 4.29038706 |
| 24 | Recurrent fungal infections (HP:0002841) | 4.28733337 |
| 25 | Keratoconjunctivitis sicca (HP:0001097) | 4.18649589 |
| 26 | Glomerulonephritis (HP:0000099) | 4.16266007 |
| 27 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.15975600 |
| 28 | Spontaneous hematomas (HP:0007420) | 4.09990342 |
| 29 | Systemic lupus erythematosus (HP:0002725) | 4.05783574 |
| 30 | Recurrent skin infections (HP:0001581) | 4.01117095 |
| 31 | Encephalitis (HP:0002383) | 3.95061492 |
| 32 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.94802453 |
| 33 | Keratoconjunctivitis (HP:0001096) | 3.88241178 |
| 34 | Hypochromic anemia (HP:0001931) | 3.75137089 |
| 35 | Abnormality of the neuromuscular junction (HP:0003398) | 3.65383134 |
| 36 | Fatigable weakness (HP:0003473) | 3.65383134 |
| 37 | Weak cry (HP:0001612) | 3.64188093 |
| 38 | Renal cell carcinoma (HP:0005584) | 3.61545905 |
| 39 | Increased IgE level (HP:0003212) | 3.60464520 |
| 40 | Abnormality of T cell physiology (HP:0011840) | 3.56985686 |
| 41 | Complement deficiency (HP:0004431) | 3.54735743 |
| 42 | Vasculitis (HP:0002633) | 3.51862973 |
| 43 | Anteriorly placed anus (HP:0001545) | 3.50031411 |
| 44 | Chest pain (HP:0100749) | 3.49672819 |
| 45 | T lymphocytopenia (HP:0005403) | 3.44349118 |
| 46 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.44298799 |
| 47 | Recurrent cutaneous fungal infections (HP:0011370) | 3.44298799 |
| 48 | Meningitis (HP:0001287) | 3.41322987 |
| 49 | Peritonitis (HP:0002586) | 3.41245367 |
| 50 | Recurrent abscess formation (HP:0002722) | 3.40255142 |
| 51 | Broad ribs (HP:0000885) | 3.35636509 |
| 52 | Episodic fever (HP:0001954) | 3.30302586 |
| 53 | Abnormality of T cell number (HP:0011839) | 3.28470251 |
| 54 | Prolonged bleeding time (HP:0003010) | 3.28291425 |
| 55 | Abnormality of the pleura (HP:0002103) | 3.22542958 |
| 56 | Gingival bleeding (HP:0000225) | 3.21772798 |
| 57 | Easy fatigability (HP:0003388) | 3.15854017 |
| 58 | Abnormality of the common coagulation pathway (HP:0010990) | 3.13971471 |
| 59 | Joint swelling (HP:0001386) | 3.10453549 |
| 60 | Truncal ataxia (HP:0002078) | 3.08663021 |
| 61 | Granulocytopenia (HP:0001913) | 3.08179333 |
| 62 | Nasolacrimal duct obstruction (HP:0000579) | 3.06085000 |
| 63 | Hemoptysis (HP:0002105) | 3.04105227 |
| 64 | Relative macrocephaly (HP:0004482) | 3.02701722 |
| 65 | Arterial thrombosis (HP:0004420) | 3.02410838 |
| 66 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.02275884 |
| 67 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.96927835 |
| 68 | Anorexia (HP:0002039) | 2.92569185 |
| 69 | Pulmonary infiltrates (HP:0002113) | 2.88819021 |
| 70 | Leukocytosis (HP:0001974) | 2.88293343 |
| 71 | Abnormality of complement system (HP:0005339) | 2.83589370 |
| 72 | Abnormality of iron homeostasis (HP:0011031) | 2.81899551 |
| 73 | Pulmonary embolism (HP:0002204) | 2.80375945 |
| 74 | Decreased muscle mass (HP:0003199) | 2.78214574 |
| 75 | Choanal stenosis (HP:0000452) | 2.77207562 |
| 76 | Eczematoid dermatitis (HP:0000976) | 2.76341064 |
| 77 | Inflammation of the large intestine (HP:0002037) | 2.74359993 |
| 78 | Lymphedema (HP:0001004) | 2.71836599 |
| 79 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.68989480 |
| 80 | Knee flexion contracture (HP:0006380) | 2.67444799 |
| 81 | Gastrointestinal inflammation (HP:0004386) | 2.64968009 |
| 82 | Recurrent bacterial skin infections (HP:0005406) | 2.63914508 |
| 83 | Pustule (HP:0200039) | 2.62361155 |
| 84 | Sporadic (HP:0003745) | 2.60952046 |
| 85 | Osteomyelitis (HP:0002754) | 2.58094254 |
| 86 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.51907795 |
| 87 | Increased IgM level (HP:0003496) | 2.50850301 |
| 88 | Recurrent viral infections (HP:0004429) | 2.47581148 |
| 89 | Nephritis (HP:0000123) | 2.42571850 |
| 90 | Type I transferrin isoform profile (HP:0003642) | 2.40611828 |
| 91 | Gangrene (HP:0100758) | 2.40240202 |
| 92 | Increased cerebral lipofuscin (HP:0011813) | 2.40052797 |
| 93 | Stomatitis (HP:0010280) | 2.38717824 |
| 94 | Reduced antithrombin III activity (HP:0001976) | 2.37352546 |
| 95 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.35388809 |
| 96 | Petechiae (HP:0000967) | 2.33098792 |
| 97 | Slow saccadic eye movements (HP:0000514) | 2.31317698 |
| 98 | Panhypogammaglobulinemia (HP:0003139) | 2.28543522 |
| 99 | Abnormality of T cells (HP:0002843) | 2.28474580 |
| 100 | Subacute progressive viral hepatitis (HP:0006572) | 2.26418492 |
| 101 | Abnormality of the intrinsic pathway (HP:0010989) | 2.25978683 |
| 102 | Toxemia of pregnancy (HP:0100603) | 2.24353388 |
| 103 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.23753320 |
| 104 | Lymphopenia (HP:0001888) | 2.23055767 |
| 105 | Abnormality of the endocardium (HP:0004306) | 2.22098799 |
| 106 | Abnormality of the lacrimal duct (HP:0011481) | 2.20050256 |
| 107 | Glomerulopathy (HP:0100820) | 2.18343205 |
| 108 | Menorrhagia (HP:0000132) | 2.13514701 |
| 109 | Action tremor (HP:0002345) | 2.12798235 |
| 110 | Keratitis (HP:0000491) | 2.12445691 |
| 111 | Acne (HP:0001061) | 2.11824103 |
| 112 | Azoospermia (HP:0000027) | 2.11235889 |
| 113 | Eosinophilia (HP:0001880) | 2.10493028 |
| 114 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.09943235 |
| 115 | Hypergammaglobulinemia (HP:0010702) | 2.08988030 |
| 116 | Vertigo (HP:0002321) | 2.07363117 |
| 117 | Abnormal platelet volume (HP:0011876) | 2.06782940 |
| 118 | Focal motor seizures (HP:0011153) | 2.05456238 |
| 119 | Acute hepatic failure (HP:0006554) | 2.05430337 |
| 120 | Hyperglycinuria (HP:0003108) | 2.05112707 |
| 121 | Deep venous thrombosis (HP:0002625) | 2.05108564 |
| 122 | Abnormality of the pericardium (HP:0001697) | 2.04626423 |
| 123 | Skin ulcer (HP:0200042) | 2.04427142 |
| 124 | Viral hepatitis (HP:0006562) | 2.02011622 |
| 125 | Skin rash (HP:0000988) | 1.98464050 |
| 126 | Loss of speech (HP:0002371) | 1.97837871 |
| 127 | Chronic otitis media (HP:0000389) | 1.96458410 |
| 128 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.94635585 |
| 129 | Amyloidosis (HP:0011034) | 1.93991408 |
| 130 | Sepsis (HP:0100806) | 1.93961513 |
| 131 | IgM deficiency (HP:0002850) | 1.91873059 |
| 132 | Recurrent pneumonia (HP:0006532) | 1.90932309 |
| 133 | Elbow flexion contracture (HP:0002987) | 1.90846189 |
| 134 | Flared metaphyses (HP:0003015) | 1.90398363 |
| 135 | Gingivitis (HP:0000230) | 1.89802007 |
| 136 | Recurrent bronchitis (HP:0002837) | 1.89654341 |
| 137 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.89521464 |
| 138 | Polycythemia (HP:0001901) | 1.89000682 |
| 139 | Thoracic kyphosis (HP:0002942) | 1.88638413 |
| 140 | Premature loss of primary teeth (HP:0006323) | 1.88008170 |
| 141 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.86975857 |
| 142 | Cellulitis (HP:0100658) | 1.85924078 |
| 143 | Vacuolated lymphocytes (HP:0001922) | 1.85457957 |
| 144 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.83447979 |
| 145 | Papilledema (HP:0001085) | 1.83226018 |
| 146 | Colitis (HP:0002583) | 1.82976572 |
| 147 | Polyneuropathy (HP:0001271) | 1.81916142 |
| 148 | Epistaxis (HP:0000421) | 1.81522387 |
| 149 | Abnormality of the nasolacrimal system (HP:0000614) | 1.80955180 |
| 150 | Hypokinesia (HP:0002375) | 1.80723833 |
| 151 | Hypermelanotic macule (HP:0001034) | 1.80699760 |
| 152 | Abnormality of macrophages (HP:0004311) | 1.80357027 |
| 153 | Abnormality of eosinophils (HP:0001879) | 1.80176556 |
| 154 | Hepatosplenomegaly (HP:0001433) | 1.79369174 |
| 155 | Cheilitis (HP:0100825) | 1.78662140 |
| 156 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.78361220 |
| 157 | Thrombophlebitis (HP:0004418) | 1.77362727 |
| 158 | Difficulty running (HP:0009046) | 1.77132228 |
| 159 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.76813433 |
| 160 | Purpura (HP:0000979) | 1.76321640 |
| 161 | Chronic obstructive pulmonary disease (HP:0006510) | 1.74736150 |
| 162 | Obstructive lung disease (HP:0006536) | 1.74736150 |
| 163 | Apathy (HP:0000741) | 1.74513514 |
| 164 | Craniofacial hyperostosis (HP:0004493) | 1.73869589 |
| 165 | Intellectual disability, moderate (HP:0002342) | 1.71307000 |
| 166 | Abnormality of the thymus (HP:0000777) | 1.68013238 |
| 167 | Urticaria (HP:0001025) | 1.67036507 |
| 168 | Gowers sign (HP:0003391) | 1.65884808 |
| 169 | Xanthomatosis (HP:0000991) | 1.62906120 |
| 170 | Abnormality of the humeroradial joint (HP:0100744) | 1.60739616 |
| 171 | Abnormal cortical bone morphology (HP:0003103) | 1.58894989 |
| 172 | Cellular immunodeficiency (HP:0005374) | 1.57760258 |
| 173 | Microcytic anemia (HP:0001935) | 1.56507162 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IKBKB | 3.46171007 |
| 2 | MST4 | 2.56342748 |
| 3 | TNK2 | 2.41677323 |
| 4 | MUSK | 14.1661233 |
| 5 | ZAP70 | 1.99799508 |
| 6 | PTK6 | 1.92450285 |
| 7 | TXK | 1.86787942 |
| 8 | PRPF4B | 1.82572295 |
| 9 | MAP4K1 | 1.77439473 |
| 10 | CAMKK2 | 1.65841398 |
| 11 | PKN2 | 1.59368082 |
| 12 | IRAK4 | 1.56977408 |
| 13 | MKNK2 | 1.54968327 |
| 14 | MAP3K13 | 1.52321829 |
| 15 | YES1 | 1.47255912 |
| 16 | SIK3 | 1.30121383 |
| 17 | KIT | 1.23095826 |
| 18 | IRAK1 | 1.15363384 |
| 19 | CAMKK1 | 1.13350557 |
| 20 | CDK19 | 1.12492113 |
| 21 | ROCK1 | 1.11814227 |
| 22 | MARK3 | 1.10759696 |
| 23 | TYK2 | 1.09194504 |
| 24 | IRAK2 | 1.06369857 |
| 25 | MARK2 | 1.06288792 |
| 26 | JAK3 | 0.96716162 |
| 27 | MAP3K12 | 0.92647400 |
| 28 | TNIK | 0.91947412 |
| 29 | CSF1R | 0.89515270 |
| 30 | FES | 0.84772553 |
| 31 | MKNK1 | 0.83450524 |
| 32 | PRKCH | 0.82954680 |
| 33 | CSNK1G1 | 0.82513039 |
| 34 | RAF1 | 0.81325471 |
| 35 | GRK6 | 0.81269995 |
| 36 | TBK1 | 0.79415365 |
| 37 | MAP3K11 | 0.79313730 |
| 38 | FLT3 | 0.78976463 |
| 39 | PTK2B | 0.78246897 |
| 40 | MAP2K3 | 0.77336388 |
| 41 | BMPR2 | 0.77303919 |
| 42 | PDPK1 | 0.76416489 |
| 43 | DYRK1B | 0.75475810 |
| 44 | SIK2 | 0.75379570 |
| 45 | TESK2 | 0.73374041 |
| 46 | KSR1 | 0.72678120 |
| 47 | FGFR3 | 0.72258748 |
| 48 | PRKG2 | 0.71289603 |
| 49 | MAP3K14 | 0.70143733 |
| 50 | SMG1 | 0.70061797 |
| 51 | MAP3K1 | 0.69596244 |
| 52 | STK11 | 0.68748797 |
| 53 | RIPK4 | 0.67904800 |
| 54 | TGFBR2 | 0.67223838 |
| 55 | STK10 | 0.66519009 |
| 56 | JAK2 | 0.66136788 |
| 57 | CSK | 0.64768245 |
| 58 | MAP3K6 | 0.64697904 |
| 59 | CSNK1D | 0.63417061 |
| 60 | TAOK1 | 0.63171133 |
| 61 | SGK3 | 0.61372956 |
| 62 | SYK | 0.61343961 |
| 63 | PRKD2 | 0.60591309 |
| 64 | CAMK4 | 0.59723895 |
| 65 | MAP3K5 | 0.58147528 |
| 66 | JAK1 | 0.58017156 |
| 67 | RIPK1 | 0.56137922 |
| 68 | PIM1 | 0.55729316 |
| 69 | CSNK1G3 | 0.55602513 |
| 70 | KSR2 | 0.54918267 |
| 71 | FGFR4 | 0.54600254 |
| 72 | CSNK1A1L | 0.54356834 |
| 73 | TTN | 0.52189501 |
| 74 | EPHA3 | 0.52161383 |
| 75 | DAPK2 | 0.52098445 |
| 76 | LRRK2 | 0.51282643 |
| 77 | ERN1 | 0.50696554 |
| 78 | MAP3K7 | 0.49082611 |
| 79 | SGK1 | 0.48927930 |
| 80 | RET | 0.48658194 |
| 81 | WNK1 | 0.48102629 |
| 82 | LCK | 0.47901995 |
| 83 | PRKG1 | 0.47164853 |
| 84 | IRAK3 | 0.46366647 |
| 85 | HIPK2 | 0.46163229 |
| 86 | BTK | 0.45622400 |
| 87 | MAP3K10 | 0.45457769 |
| 88 | TAOK3 | 0.44321515 |
| 89 | SGK2 | 0.43873300 |
| 90 | HCK | 0.43625983 |
| 91 | FYN | 0.43562713 |
| 92 | FGR | 0.42813532 |
| 93 | EPHB1 | 0.42389724 |
| 94 | MAP2K7 | 0.41362310 |
| 95 | MAP3K8 | 0.40103032 |
| 96 | PRKCZ | 0.39486546 |
| 97 | NLK | 0.39122434 |
| 98 | MAPK7 | 0.38488513 |
| 99 | TRIB3 | 0.38282532 |
| 100 | MAP3K3 | 0.38009968 |
| 101 | IGF1R | 0.38003298 |
| 102 | MAP3K9 | 0.37721509 |
| 103 | LYN | 0.36765348 |
| 104 | MATK | 0.36576358 |
| 105 | MAPKAPK2 | 0.36253663 |
| 106 | SCYL2 | 0.35922215 |
| 107 | STK38 | 0.35682684 |
| 108 | SIK1 | 0.34571610 |
| 109 | AKT1 | 0.34519518 |
| 110 | CDC42BPA | 0.34338839 |
| 111 | CSNK1G2 | 0.34154720 |
| 112 | TEC | 0.33520371 |
| 113 | MAPK4 | 0.33297563 |
| 114 | MAP2K6 | 0.33100696 |
| 115 | DYRK3 | 0.32129621 |
| 116 | RPS6KC1 | 0.31093741 |
| 117 | RPS6KL1 | 0.31093741 |
| 118 | ITK | 0.30246111 |
| 119 | PAK1 | 0.27852462 |
| 120 | ABL2 | 0.27522454 |
| 121 | RPS6KA6 | 0.26946922 |
| 122 | ERBB4 | 0.25344633 |
| 123 | AKT2 | 0.24960831 |
| 124 | TAOK2 | 0.24821891 |
| 125 | CSNK2A1 | 0.23301956 |
| 126 | IKBKE | 0.23269191 |
| 127 | PIK3CG | 0.21311422 |
| 128 | CAMK1 | 0.19448472 |
| 129 | MAPK3 | 0.18766947 |
| 130 | CHEK1 | 0.18642179 |
| 131 | BLK | 0.17715119 |
| 132 | CLK1 | 0.17541727 |
| 133 | PRKCQ | 0.16629291 |
| 134 | PRKCD | 0.15952152 |
| 135 | TLK1 | 0.15493370 |
| 136 | KDR | 0.15480513 |
| 137 | PDK1 | 0.15362871 |
| 138 | MAP3K2 | 0.15352207 |
| 139 | MAPK12 | 0.14086867 |
| 140 | NEK9 | 0.13661139 |
| 141 | MAP2K4 | 0.13408504 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 5.32800722 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 5.03051197 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.30849515 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.89210831 |
| 5 | PPAR signaling pathway_Homo sapiens_hsa03320 | 3.11551446 |
| 6 | Base excision repair_Homo sapiens_hsa03410 | 2.85906445 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.82911217 |
| 8 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.48569428 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.37314327 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.23618987 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.14174535 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 2.03084649 |
| 13 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.01131299 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 1.99038814 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.94510739 |
| 16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.92707650 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.84154845 |
| 18 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.83370119 |
| 19 | ABC transporters_Homo sapiens_hsa02010 | 1.64282196 |
| 20 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.51847385 |
| 21 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.51317778 |
| 22 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.50626704 |
| 23 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.47613744 |
| 24 | DNA replication_Homo sapiens_hsa03030 | 1.46357336 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 1.45371842 |
| 26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.45263842 |
| 27 | Insulin resistance_Homo sapiens_hsa04931 | 1.43890361 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.40484205 |
| 29 | Hepatitis C_Homo sapiens_hsa05160 | 1.38406541 |
| 30 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.30521561 |
| 31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.30492655 |
| 32 | Apoptosis_Homo sapiens_hsa04210 | 1.28044412 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.26388578 |
| 34 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.25323092 |
| 35 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.25224083 |
| 36 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.22221788 |
| 37 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.21640823 |
| 38 | Prion diseases_Homo sapiens_hsa05020 | 1.21368072 |
| 39 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.16726337 |
| 40 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.11399777 |
| 41 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.09868250 |
| 42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.07725002 |
| 43 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.07501642 |
| 44 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.07370102 |
| 45 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.05566905 |
| 46 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.01767799 |
| 47 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.96300427 |
| 48 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.94905421 |
| 49 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.94629303 |
| 50 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.93523680 |
| 51 | Endocytosis_Homo sapiens_hsa04144 | 0.91623070 |
| 52 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.89705431 |
| 53 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.89270807 |
| 54 | Endometrial cancer_Homo sapiens_hsa05213 | 0.86492336 |
| 55 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.84774265 |
| 56 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.83736305 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.83131753 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.83105981 |
| 59 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.82065842 |
| 60 | Mineral absorption_Homo sapiens_hsa04978 | 0.81698503 |
| 61 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.80179311 |
| 62 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.80016268 |
| 63 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.77135740 |
| 64 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.77135506 |
| 65 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77027730 |
| 66 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.77023921 |
| 67 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.76708914 |
| 68 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.76616000 |
| 69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.76056162 |
| 70 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.73617420 |
| 71 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70413729 |
| 72 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.69172504 |
| 73 | Legionellosis_Homo sapiens_hsa05134 | 0.69049790 |
| 74 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.68619127 |
| 75 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.67325249 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67189487 |
| 77 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.67153757 |
| 78 | Colorectal cancer_Homo sapiens_hsa05210 | 0.66877928 |
| 79 | Amoebiasis_Homo sapiens_hsa05146 | 0.66514363 |
| 80 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65298556 |
| 81 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.65123301 |
| 82 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.65052902 |
| 83 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.64800853 |
| 84 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.64126088 |
| 85 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.63832847 |
| 86 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.63747424 |
| 87 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.63132576 |
| 88 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62853431 |
| 89 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.62065201 |
| 90 | Proteasome_Homo sapiens_hsa03050 | 0.61997478 |
| 91 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60822839 |
| 92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59684995 |
| 93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58426121 |
| 94 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.56962463 |
| 95 | Phagosome_Homo sapiens_hsa04145 | 0.55860915 |
| 96 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55774300 |
| 97 | Other glycan degradation_Homo sapiens_hsa00511 | 0.54954451 |
| 98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54368653 |
| 99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54108983 |
| 100 | Thyroid cancer_Homo sapiens_hsa05216 | 0.53093469 |
| 101 | Asthma_Homo sapiens_hsa05310 | 0.53000387 |
| 102 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50435591 |
| 103 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.50118074 |
| 104 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49697132 |
| 105 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.49519114 |
| 106 | Long-term depression_Homo sapiens_hsa04730 | 0.47993289 |
| 107 | Shigellosis_Homo sapiens_hsa05131 | 0.47121133 |
| 108 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46943634 |
| 109 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.45993242 |
| 110 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.45305557 |
| 111 | Prostate cancer_Homo sapiens_hsa05215 | 0.44177132 |
| 112 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.43873068 |
| 113 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.42933682 |
| 114 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.42924947 |
| 115 | Glioma_Homo sapiens_hsa05214 | 0.42838592 |
| 116 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.42773811 |
| 117 | Bile secretion_Homo sapiens_hsa04976 | 0.42212974 |
| 118 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.39997245 |
| 119 | Lysosome_Homo sapiens_hsa04142 | 0.39229652 |
| 120 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.38644541 |
| 121 | Peroxisome_Homo sapiens_hsa04146 | 0.38188184 |
| 122 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.38180768 |
| 123 | Measles_Homo sapiens_hsa05162 | 0.38160740 |
| 124 | Salmonella infection_Homo sapiens_hsa05132 | 0.38099464 |
| 125 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.37231145 |
| 126 | Histidine metabolism_Homo sapiens_hsa00340 | 0.36723293 |
| 127 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.34025743 |
| 128 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.32082152 |
| 129 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.31764125 |
| 130 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.31091560 |
| 131 | Hepatitis B_Homo sapiens_hsa05161 | 0.30099543 |
| 132 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.27566519 |
| 133 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.25492578 |
| 134 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.24881884 |
| 135 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.24651257 |
| 136 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.23579074 |
| 137 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.23509891 |
| 138 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.23447525 |
| 139 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.22708264 |
| 140 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.22142115 |
| 141 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.21160997 |
| 142 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.19791510 |
| 143 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.18457174 |
| 144 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.18131946 |
| 145 | Viral myocarditis_Homo sapiens_hsa05416 | 0.15762655 |
| 146 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.14520545 |
| 147 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.14253986 |
| 148 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14062939 |
| 149 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.13592544 |

